PATENT CLAIM ANALYSIS

Application Number: 16277986
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-08
Patent Classification: ["514", "252100"]

Abstract:
Disclosed is a stable oral liquid pharmaceutical composition of trimetazidine having a pH of about pH 4 to about pH 8, comprising a therapeutically effective amount of trimetazidine or a pharmaceutically acceptable salt thereof, one or more orally acceptable buffers, and one or more orally acceptable preservatives that is effective in said pH range. Also disclosed are methods of treating patients with stable oral liquid pharmaceutical composition. The pharmaceutical composition is particularly suitable for treating a patient having a condition treatable by trimetazidine, such as cirrhosis and renal deficiency, and who has a decreased tolerance for acidic or highly basic oral solutions.

Claim (Index 13):
A method of treating a patient having a condition treatable by trimetazidine and who has a decreased tolerance for acidic or highly basic oral solutions, comprising administering the composition according to  claim 1 .

Metadata:
- Claim Count in Document: 38.0
- Percentile: 99.0
- Lexical Diversity: 1.69231
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13446940', '13787437', '10841709', '11159027', '14087903']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7090416028964754
- 35 USC 102 Novelty (BERT): 0.4872342072682836
- Combined Prediction Score: 0.6868608633336563
- Mean Citation Score: 172.046446
- Max Citation Score: 179.14311
- Similarity Product: 121.59514389914274

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test